PHARMACEUTICAL THERAPEUTIC PRODUCTS

Brand Owner (click to sort) Address Description
ALPHA PLASMA CENTERS ALPHA THERAPEUTIC CORPORATION 5555 Valley Boulevard Los Angeles CA 90032 pharmaceutical and therapeutic products, namely, plasma expanders in the nature of human albumin and human plasma protein fraction, coagulation products, namely, human anti-hemophilic factor, transferrin, human factor IX; immune serum globulin, anti-thrombin III, intravenous fat emulsion and source plasma;medical containers, namely, plastic containers, tubing and fittings for use in collection and storage of human blood products and derivatives;PLASMA CENTERS;OPERATION OF COMMERCIAL BLOOD DONOR CENTERS, TESTING AND ANALYSIS OF HUMAN BLOOD PRODUCTS AND DERIVATIVES;
ALPHA PLASMA CENTERS ALPHA THERAPEUTIC CORPORATION 5555 Valley Boulevard Los Angeles CA 90032 PHARMACEUTICAL AND THERAPEUTIC PRODUCTS, NAMELY, PLASMA EXPANDERS IN THE NATURE OF HUMAN ALBUMIN, COAGULATION PRODUCTS, NAMELY, HUMAN ANTI-HEMOPHILIC FACTOR, TRANSFERRIN, HUMAN FACTOR IX; IMMUNE SERUM GLOBULIN, ANTI-THROMBIN III, INTRAVENOUS FAT EMULSION AND SOURCE PLASMA;MEDICAL CONTAINERS, NAMELY, PLASTIC CONTAINERS, TUBING AND FITTINGS FOR USE IN COLLECTION AND STORAGE OF HUMAN BLOOD PRODUCTS AND DERIVATIVES;PLASMA CENTERS;OPERATION OF COMMERCIAL BLOOD DONOR CENTERS, TESTING AND ANALYSIS OF HUMAN BLOOD PRODUCTS AND DERIVATIVES;
ALPHA THERAPEUTIC CORPORATION ALPHA THERAPEUTIC CORPORATION 5555 Valley Boulevard Los Angeles CA 90032 PHARMACEUTICAL AND THERAPEUTIC PRODUCTS, NAMELY, ALBUMIN (HUMAN); PLASMA PROTEIN FRACTION (HUMAN); ANTIHEMOPHILIC FACTOR (HUMAN); IMMUNE GLOBULIN INTRAVENOUS (HUMAN); INTRAVENOUS FAT EMULSION, AND SOURCE PLASMA;FIRST USED IN COMMERCE IN ANOTHER FORM ON AUGUST 16, 1979;FIRST USED IN ANOTHER FORM ON APRIL 16, 1979;CORPORATION;
CARIDIANBCT GAMBRO BCT, INC. IP Department 10810 West Collins Avenue Lakewood CO 80215 Pharmaceutical and therapeutic products, namely for use in blood component technology and regenerative medicine, namely anti-coagulant and blood and cell storage and treatment solutions, and therapeutic cell treatments;
CARIDIANBCT TERUMO BCT, INC. 10811 W. Collins Avenue Lakewood CO 80215 Pharmaceutical and therapeutic products, namely, for use in blood component technology and regenerative medicine, namely, anti-coagulant treatment preparations for medical use, and blood and cell storage and treatment preparation solutions for storing and treating blood components for transfusions for medical use, and therapeutic cell treatment preparations for therapeutic treatments for medical use, and pathogen reduction treatment preparation for treating collected blood and blood components for medical use;
CELL BEHAVIOR TARGETED MEDICINES Cellarity, Inc. 101 South Street, Suite 600 Somerville MA 02143 Pharmaceutical and therapeutic products for the treatment of hematological diseases and disorders, cancer, immunological diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders, and respiratory diseases and disorders;Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis, namely, drug discovery and development; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research;
STATPLAS TERUMO BCT, INC. 10811 W. Collins Avenue Lakewood CO 80215 Pharmaceutical and therapeutic products, namely, processed blood components adapted for re-constitution into a transfusable solution;
STATPLAS TERUMO BCT, INC. 10811 W. Collins Avenue Lakewood CO 80215 Pharmaceutical and therapeutic products, namely, processed blood components adapted for re-constitution into a transfusable solution;Extracorporeal blood handling apparatus used for apheresis, blood component separation, filtering, therapeutic blood treatments, pathogen reduction and treatment of collected blood and blood components, namely, blood collection apparatus, blood washing apparatus, apparatus for separating collected blood into blood components, apheresis apparatus for collecting blood from a donor and for returning uncollected blood components, filters for filtering biologic fluids, blood mixers, blood containers and disposables for blood collection and treatment, namely, blood tubing sets, blood collection bags, blood storage bags, bag sets and filters; apheresis and blood washing machines, apparatus for lyophilizing blood components to form a lyophilized component for re-constitution and for therapeutic blood treatment and disposables and accessories therefor;
TOLERION Tolerion, Inc. 321 Dedalera Drive Portola Valley CA 94028 Pharmaceutical and therapeutic products for inducing immune tolerance, namely, biological preparations for use in regulating the human immune system;The wording TOLERION has no meaning in a foreign language.;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. An agent for treatment of metabolic bone disease, which contains EPO as an active ingredient, or a method for treating a patient with metabolic bone disease, which comprises EPO, is provided. Pharmaceutical products containing EPO as the active ingredient are novel prophylactic and therapeutic agents which show an ameliorative action by healing bone and bone marrow lesions in bone disease, especially bone disease based on impaired bone metabolism, aside from the previously reported erythrocyte increasing action of EPO. Pathological states, targeted by these pharmaceutical products, are bone diseases showing metabolic bone disorders, including renal failure-associated osteodystrophy, marble bone disease, diabetic nephropathy, and osteoporosis.